Your search for selected publications came up with 45 results
China's economy looks to be well on its way to recovering
from the coronavirus-imposed lockdown with consumer spending, manufacturing and
investment bouncing back. But can we trust China's macro numbers? Sinology
In response to White House pressure, the retirement fund for U.S. federal workers has postponed a decision to provide participants with the option to invest in Chinese-listed companies. Sinology answers some key questions related to this decision.
China's macro numbers for the first quarter were weak, but China appears to have brought COVID-19 under control as March data signals China is on the road to recovery. Sinology explores how China's economy could put a floor under global growth, offering opportunities for investors if China prevents a second wave of cases and continues supporting small, privately owned firms.
When thinking about prospects for the Chinese economy through the rest of 2020, one of the most important factors is whether coronavirus remains under control. With the country's domestic-demand driven economy set to rebound, is China a safe haven?
In our latest issue of Sinology, Andy Rothman answers key questions from investors about the new coronavirus, COVID-19.
Testimony of Andy Rothman to the U.S. Economic and Security Review Commission Hearing on China's Quest for Capital.
Macro data for 2019 should set the stage for healthy economy and stronger market sentiment in China in 2020, but is there a risk of a return to tense relations between Washington and Beijing in 2021 and beyond?
The U.S.–China trade deal announced on Friday is disappointing. What does it mean
A trade deal is expected when Presidents Trump and Xi meet in November, but even if the talks fail, Sinology explains why China can mitigate the impact and maintain the world's best consumer story.
Sinology explains how the decision by the Trump administration to tag China as a currency manipulator was either a sign of panic, or a cunning plan. Or a bit of both.